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  Basip and clinical studies were made． on Cefmenoxime （CMX）， a new cephalosporin antibiotic，
and the following resuits were obtained．
  The serum concentration of CMX was examined in four healthy aduits after administration
of 250 mg of CMX by intramuscular injection， intravenous injection and onerhour intravenous drip
infusion （cross over）． ln the case ofintrarnuscular injection， the peak yalue of 5．9 ptgtml ’was obtained
30 rninutes after administration， and the half－iife in serum was 1．41 hours． ln the case of intravenous
injection， a concentration value of 11．1 yg／ml on the average was obtained after 15 minutes of ad－
1n三nistration， and亡he half」1三fe in serum was 126 hours．．In the case of intravenous drip infUsion，
the concentration was i 2．4 ptgtml upon completion of drip infusion， and CMX disappeared from
serum at a half－life of O．94 hour． The urinary recovery up to’ 6 hours was from 60 to 700／． in each
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case．
  The edicacy rate of this preparatien was I OOO／． for 4 cases of acute sirnple cystitis． The eMcacy
rate of CMX was 700／， for 10 cases of complicated urinary tract infection； the 3 cases in which
CMX was not effective were patients with a residual catheter and Pseudomonas persisting or appearing
as superinfectign． lt was noted that Serratia， which was resistant to the conventional cephalosporin
antibiotics， became negative．
  No subjective side effects due to the administration of this preparation were observed． As for
abnormal laboratory findings， a slight and transient rise in transaminases was observed in one case・
  On the basis of the above－mentioned results， it was concluded that CMX is an effective prep－
aratien for the treatment of urinary tract infections．



























 筋注群：CMX 250 mgを0。5％carbocain溶液2
mlに溶解したのち，筋肉内に投与した．
 静注群：CMX 250 mgを生理：食塩液20 mlに溶
解したのち，5分閻をかけてゆっくり静脈内に投与し
た．
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 Fig． 2． ？lasma levels of CMX in 4・ healthy male adults after
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Fig． 3． Urinary concentration and recovery of CMX in 4 healthy
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Table 2． ． Clinical efficacy of CMX on complicate．d UTI （250 mg x 2／day， d．i． 5 day）
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Table 4． Laboratery findings before and after the therapy with CMX
a） Uncomplicated UT．1．
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B ： Before the therapy A ： After the therapy
    b）C・皿pli・。t・d U。T．1．
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